- Home
- COCH vs FRMM Comparison
COCH vs FRMM Comparison
Compare COCH & FRMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$4.71
Company Overview
Basic Information| Metric | COCH | FRMM |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | 47 | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.1M | 54.9M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | COCH | FRMM |
|---|---|---|
| Price | $0.64 | $4.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.00 | $5.00 |
| AVG Volume (30 Days) | 152.8K | ★ 2.9M |
| Earning Date | 05-12-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.58 | $183.55 |
| Revenue Next Year | N/A | $166.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $1.76 |
| 52 Week High | $1.91 | $5.62 |
Technical Indicators
Market Signals| Indicator | COCH | FRMM |
|---|---|---|
| Relative Strength Index (RSI) | 47.62 | 65.54 |
| Support Level | $0.64 | $2.64 |
| Resistance Level | $0.73 | $5.55 |
| Average True Range (ATR) | 0.05 | 0.66 |
| MACD | -0.00 | 0.26 |
| Stochastic Oscillator | 52.44 | 79.53 |
Price Performance
Historical Comparison COCH
FRMM
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.